Introduction
============

Diabetes mellitus (DM) seriously endangers human health, and its incidence is rapidly growing and is becoming a trend in patients of younger age. Worldwide, the population of patients with diabetes is expected to reach 43 billion 900 million by 2030, and about three-quarters of the diabetic patients die from cardiovascular disease.[@b1-ijn-13-1945] Diabetic cardiomyopathy (DCM) is caused by diabetes with a heart structure and function disorder, independent of hypertension, coronary atherosclerotic heart disease, valvular heart disease, and other known heart diseases. DCM causes diastolic and/or systolic cardiac function changes, which may eventually lead to myocardial ischemia and heart failure, becoming one of the leading causes of death in diabetics.[@b2-ijn-13-1945] The pathogenesis of DCM is very complex and has not been fully elucidated. The current study shows that glucose and lipid metabolism disorders, myocardial fibrosis, oxidative stress, inflammation, apoptosis, and mitochondrial damage play a key role in the pathogenesis of DCM.[@b3-ijn-13-1945]--[@b7-ijn-13-1945]

Following NO and CO, hydrogen sulfide (H~2~S) is a newly discovered endogenous gas signaling molecule that exhibits physiological functions similar to NO, such as vasodilation and apoptosis.[@b8-ijn-13-1945],[@b9-ijn-13-1945] Endogenous H~2~S is produced via cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and cysteine transferase in cells. The distribution of the three key enzymes is not the same in vivo: CBS mainly exists in the nervous system (where CSE is absent), and CSE is mainly distributed in the cardiovascular system and the pancreas, such as heart, aorta, pulmonary artery, mesenteric artery, caudal artery, cerebral artery, portal vein, and the beta cells of the pancreas.[@b10-ijn-13-1945] The important biological effect of H~2~S is regulating the apoptosis of cells.[@b11-ijn-13-1945]--[@b13-ijn-13-1945] Studies have reported that H~2~S is involved in the regulation of apoptosis in cardiomyocytes and that H~2~S mainly inhibits apoptosis in the cardiovascular system.[@b11-ijn-13-1945]--[@b13-ijn-13-1945] The present study shows that endogenous H~2~S exists widely in the cardiovascular tissues and regulates myocardial function, and inhibits the apoptosis of myocardial cells.[@b14-ijn-13-1945]--[@b16-ijn-13-1945] In our study, the increase of free calcium in the cells by calmodulin (CaM) and CSE (H~2~S generating enzymes) interaction to impel activation of CSE, and increase H~2~S production;[@b12-ijn-13-1945] the high expression of CSE can inhibit cell apoptosis, and the cells from *CSE* gene knockout mice show obvious apoptosis.[@b13-ijn-13-1945]

The calcium-sensing receptor (CaSR) is a member of G protein-coupled receptor family C group. CaSR is mainly distributed in the parathyroid gland, heart, kidney, gastrointestinal tract, bone tissue, and other cells such as placenta, lens, breast, and pancreatic beta cells. CaSR not only modulates calcium homeostasis but also regulates cell proliferation, apoptosis, differentiation, and hormone secretion.[@b17-ijn-13-1945] Recent studies show that CaSR regulates DCM.[@b18-ijn-13-1945] On the other side, some studies show that abnormal regulation of Ca^2+^ in cells is involved in the development of DCM.[@b18-ijn-13-1945] A lot of studies also confirm that CaSR promotes the release of Ca^2+^ from the endoplasmic reticulum and increases intracellular calcium in cardiomyocytes.[@b19-ijn-13-1945],[@b20-ijn-13-1945] In addition, the increase of intracellular calcium can enhance the activity of CaM and regulate a variety of physiological functions, and in turn Ca^2+^/CaM can regulate the activity of CSE and the formation of H~2~S, and ultimately affect apoptosis in the cardiovascular systems.[@b21-ijn-13-1945],[@b22-ijn-13-1945]

Curcumin, a well-known dietary pigment, derives from *Curcuma longa*, and modern pharmacological studies show that curcumin has a wide range of pharmacological effects, such as antioxidant, antitumor, anti-inflammatory, and hypolipidemic effects.[@b23-ijn-13-1945]--[@b26-ijn-13-1945] Many studies have shown that curcumin has therapeutic effects on diabetes, diabetic nephropathy, diabetic eye disease, insulin resistance and metabolism-related diseases, and diabetes-induced endothelial dysfunction.[@b27-ijn-13-1945]--[@b31-ijn-13-1945] Recent studies have shown that curcumin alleviates DCM.[@b2-ijn-13-1945],[@b32-ijn-13-1945],[@b33-ijn-13-1945] However, curcumin has very low water solubility and low bioavailability which limits its clinical application.[@b34-ijn-13-1945] The process of curcumin on intestinal absorption induces biotransformation and curcumin is rarely absorbed into the bloodstream by an original drug.[@b35-ijn-13-1945],[@b36-ijn-13-1945] In order to improve the solubility of curcumin or dispersion in aqueous solution and increase its biological activity, we synthetized poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate) (PBLG-PEG-PBLG) ([Figures 1](#f1-ijn-13-1945){ref-type="fig"} and [S1](#SD1-ijn-13-1945){ref-type="supplementary-material"}) as potential curcumin carriers. The block multipolymer was synthesized via the ring-opening polymerization of BLG-N-carboxyanhydride (NCA) with H~2~N-PEG-NH~2~ as the macroinitiator. The PBLG-PEG-PBLG and curcumin integrated into a compound via hydrophobic functions ([Scheme 1](#f10-ijn-13-1945){ref-type="fig"}). In this study, the loading of curcumin into PBLG-PEG-PBLG, the release of curcumin from PBLG-PEG-PBLG, as well as the anti-DCM effect of curcumin/PBLG-PEG-PBLG were measured. The loaded curcumin showed stable release, thus enabling further research on the protective action of curcumin. Curcumin loading and in vitro release were confirmed by dialysis and ^1^H NMR. In vivo studies indicated that curcumin/PBLG-PEG-PBLG significantly reduced DCM via cross regulation effect of CaSR and CSE/H~2~S.

Materials and methods
=====================

Materials
---------

BLG was supplied from Aladdin (Shanghai, China); H~2~N-PEG-NH~2~ (molecular weight=5,000 Da) was supplied from Aladdin; curcumin was bought from Shaanxi Sciphar Biotechnology Co., Ltd. (Xian, China); H9C2 cells were purchased from Shanghai Meixuan Biological Science and Technology Co. Ltd. (Shanghai, China); streptozotocin (STZ) and other reagents were bought from Sigma-Aldrich Co. (St Louis, MO, USA).

Methods
-------

### Synthesis of PBLG-PEG-PBLG (P)

P was synthesized according to the procedures described previously.[@b37-ijn-13-1945],[@b38-ijn-13-1945] P was obtained by ring-opening polymerization of BLG-NCA with H~2~N-PEG-NH~2~ as the macroinitiator. The right proportion of H~2~N-PEG-NH~2~ in N, N-dimethylformamide (DMF) was mixed with BLG-NCA/DMF fluid via vacuumization and N~2~ protection. The corresponding compound was stirred at 30°C for 72 h and then dialyzed for 72 h. The P compound was obtained by freeze drying; the degree of polymerization of PBLG was 50, and the final product was measured via ^1^H-nuclear magnetic resonance (^1^H NMR).

### Cytotoxicity measurement of P and curcumin/P

For a detailed measurement of cytotoxicity by the cell culture and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay (H9C2 cells were selected) of P and curcumin/P, please refer to our previous studies.[@b39-ijn-13-1945]--[@b43-ijn-13-1945]

### Loading of curcumin by P

To observe the encapsulation of curcumin by P, a right amount of curcumin (5 mg/mL) in phosphate buffered saline (PBS) solution (pH=7.2, 0.01 mmol/L) was mixed with P solubilized in PBS and then the obtained solution was dialyzed. The P-encapsulated curcumin was measured through high-pressure liquid chromatography (HPLC), transmission electron microscopy (TEM), and particle size analyzer.

### Curcumin release in vitro

Release of curcumin from P was observed via a dialysis method at 37°C, with 5 mL of curcumin-encapsulated P against a PB buffer. The curcumin/P complex solutions were prepared as described in the section "Loading of curcumin by P". At fixed time intervals, the amount of curcumin released was observed via HPLC.

### Blood curcumin level observation

Sprague Dawley (SD) male rats (170--250 g) were administrated a dose of 20 mg/kg curcumin or curcumin/P by abdominal subcutaneous injection. About 0.2 mL of the blood was extracted at fixed time intervals and was subjected to centrifugation (12,000× *g* for 20 min at 4°C). The levels of curcumin and curcumin/P in the rat blood were determined by HPLC.

### Diabetic animal model

SD male rats (170--250 g) were obtained from Jiaxing University, Medical College, Jiaxing, China. The procedures and care of SD male rats were authorized through the Institutional Ethics Committee of Jiaxing University, Medical College, Jiaxing, China. The expedition conformed to the guide for the care and use of laboratory animals published through US National Institutes of Health (NIH Publication updated in 2011). SD rats were administrated a high-fat diet (fat content 40%) for 10 weeks and then STZ was injected only once at a dose of 35 mg/kg into the abdominal cavity. After 3 days, diabetes was observed by measuring blood glucose level using glucose oxidase-peroxidase (GOD-POD) ways.[@b44-ijn-13-1945] Animals which had blood glucose level \>16.7 mmol/L were used for further studies.

### Histopathological assessment, blood glucose, cholesterol (Chol), triglyceride (TG), and insulin levels in DM-4w/8w group

Ten SD rats and 20 diabetic rats were assigned to three groups (n=10, each group): 1) Sham group, 2) DM-4w group, and 3) DM-8w group. At a fixed time interval, histopathological changes, and blood glucose, Chol, TG, and insulin levels were measured via previous methods.[@b18-ijn-13-1945],[@b44-ijn-13-1945],[@b45-ijn-13-1945] In brief, the myocardium was fixed in 4% paraformaldehyde, paraffin-embedded, sliced into 4 μm sections, and stained with hematoxylin-eosin (HE) staining. The pathological changes at the cellular level were observed under the microscope (Leica Microsystems, Wetzlar, Germany) and graded according to the degree of injury based on the percentage of involvement of the myocardium. The extent of injury pertaining to the 10 areas corresponding to the myocardium was graded using the following parameters: hemorrhage, myocardial edema (cytoplasmic vacuole formation), cardiomyocyte apoptosis, and myocardial necrosis based on a 5-point evaluation system (1= histopathological changes \<10%; 2=10%--25%; 3=25%--50%; 4=50%--75%; and 5=75%--100%). The mean score for each parameter was calculated and subjected to statistical analysis.

### CaSR and CSE expression in DM-4w/8w group

CaSR and CSE expression were measured via immunohistochemical methods in Sham, DM-4w, and DM-8w groups following the methods described previously.[@b46-ijn-13-1945],[@b47-ijn-13-1945]

### CaSR and CSE expression in DM-8w+CaRS and DM-8w+CaRS+PAG

Ten SD rats and 10 diabetic rats were assigned to two groups (n=10, each group): Sham group and DM8w+CaRS group. Diabetic rats were administered calcium-sensing receptor stimulator (CaRS) (R-568; 250 μg/d) through intraperitoneal injection. CaSR and CSE expression were measured via immunohistochemical methods following the methods described in previous studies.[@b46-ijn-13-1945],[@b47-ijn-13-1945] Ten SD rats and 10 diabetic rats were assigned to two groups (n=10, each group): Sham group and DM-8w+CaRS+PAG group. Diabetic rats were administered CaRS (R-568; 250 μg/d) and DL-propargylglycine (PAG) (50 mg/kg/d) through intraperitoneal injections, respectively. CSE expression was measured via immunohistochemical methods described previously.[@b47-ijn-13-1945] All the dosages were selected according to those mentioned in the previous works.[@b48-ijn-13-1945],[@b49-ijn-13-1945]

### Histopathologic assessment, CaSR, CSE, and CaM expression, H~2~S and \[Ca^2+^\]~i~ levels (effect of CaRS and CaRI)

Ten SD rats and 70 diabetic rats were assigned to eight groups (n=10, each group): 1) Sham group; 2) DM-8w group; 3) Curcumin group: diabetic rats were administered curcumin (20 mg/kg/d) through hypodermic injection for 8 weeks; 4) Curcumin/PBLG-PEG-PBLG (Curcumin/P) group: diabetic rats were administered curcumin/P (20 mg/kg/3 d) through hypodermic injection for 8 weeks; 5) Curcumin+CaRS group: diabetic rats were administered curcumin (20 mg/kg/d) through hypodermic injection and CaRS (R-568; 250 μg/d) through intraperitoneal injection for 8 weeks; 6) Curcumin/P+CaRS group: diabetic rats were administered curcumin/P (20 mg/kg/3 d) through hypodermic injection and CaRS (R-568; 250 μg/d) through intraperitoneal injection for 8 weeks; 7) Curcumin+CaRI group: diabetic rats were administered curcumin (20 mg/kg/d) through hypodermic injection and CaRI (NPS2390; 1.5 mg/kg/d) through intraperitoneal injection for 8 weeks; and 8) Curcumin/ P+CaRI group: diabetic rats were administered curcumin/P (20 mg/kg/3 d) through hypodermic injection and CaRI (NPS2390; 1.5 mg/kg/d) through intraperitoneal injection for 8 weeks. At a fixed time interval, histopathologic changes (identical to the abovementioned method); CaSR, CSE, and CaM expression (immunohistochemical methods); and H~2~S and \[Ca^2+^\]~i~ levels were measured via previous methods.[@b45-ijn-13-1945]--[@b47-ijn-13-1945],[@b50-ijn-13-1945],[@b51-ijn-13-1945] All dosages were in accordance with previous studies.[@b48-ijn-13-1945],[@b52-ijn-13-1945],[@b53-ijn-13-1945]

### Histopathologic assessment, H~2~S level, and CSE expression (effect of CaRS and PAG)

Ten SD rats and 70 diabetic rats were assigned to eight groups (n=10, each group): 1) Sham group; 2) DM-8w group; 3) Curcumin group: diabetic rats were administered by curcumin (20 mg/kg/d) through hypodermic injection for 8 weeks; 4) Curcumin/PBLG-PEG-PBLG (Curcumin/P) group: diabetic rats were administered by curcumin/P (20 mg/kg/3 d) through hypodermic injection for 8 weeks; 5) Curcumin+PAG group: diabetic rats were administered curcumin (20 mg/kg/d) through hypodermic injection and PAG (50 mg/kg/d) through intraperitoneal injection for 8 weeks; 6) Curcumin/P+PAG group: diabetic rats were administered curcumin/P (20 mg/kg/3 d) through hypodermic injection and CaRS (50 mg/kg/d) through intraperitoneal injection for 8 weeks; 7) Curcumin+CaRS+PAG group: diabetic rats were administered curcumin (20 mg/kg/d) through hypodermic injection, and CaRS (R-568; 250 μg/d) and PAG (50 mg/kg/d) through intraperitoneal injection for 8 weeks; 8) Curcumin/P+CaRS+PAG group: diabetic rats were administered curcumin/P (20 mg/kg/3 d) through hypodermic injection and CaRS (R-568; 250 μg/d) and PAG (50 mg/kg/d) through intraperitoneal injection for 8 weeks. At a fixed time interval, histopathologic changes (identical to the abovementioned method), H~2~S level, and CSE expression (immunohistochemical methods) were measured via previous methods.[@b45-ijn-13-1945],[@b47-ijn-13-1945],[@b50-ijn-13-1945] All dosages were in accordance with previous studies.[@b48-ijn-13-1945],[@b49-ijn-13-1945],[@b53-ijn-13-1945]

### Apoptosis assessment

Apoptosis assessment of cardiac cells in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups (the grouping was the same as that mentioned earlier) were observed via previous literatures;[@b54-ijn-13-1945] apoptosis assessment of cardiac cell in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups (the grouping was the same as that mentioned earlier) were observed via previous literatures.[@b54-ijn-13-1945]

Statistical analysis
--------------------

Data were expressed as mean ± standard deviation. All analyses were actualized through SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). *p*\<0.01 was considered to show a statistically significant difference.

Results and discussion
======================

Synthesis and characterization of PBLG-PEG-PBLG (P)
---------------------------------------------------

P was composed of one PEG and two PBLG molecules ([Figures 1](#f1-ijn-13-1945){ref-type="fig"} and [S1](#SD1-ijn-13-1945){ref-type="supplementary-material"}). In the present study, the molecular weight of PEG was 5,000 Da, and the degree of polymerization of the PBLG was 50. The procedure of synthesis is described in [Figure S1](#SD1-ijn-13-1945){ref-type="supplementary-material"}. The ^1^H NMR spectra of PBLG-PEG-PBLG is depicted in [Figure S2A](#SD2-ijn-13-1945){ref-type="supplementary-material"} and [Table S1](#SD4-ijn-13-1945){ref-type="supplementary-material"}, and the characteristic proton peaks of both PEG and PBLG were observed, corroborating the fact that the synthesis proceeded in a controlled manner and was successful.

Cellular viability measurement
------------------------------

The cell toxicity of P and curcumin/P on H9C2 cells were assessed in 24-hour cultures and the results are depicted in [Figure S3](#SD3-ijn-13-1945){ref-type="supplementary-material"}. The P and curcumin/P micelles showed low cell toxicity even at a concentration as high as 250 μg/mL.

Loading capacity of curcumin into P
-----------------------------------

Curcumin could be efficiently loaded into P at pH 7.4 through the hydrophobic interactions. Curcumin was added to P (mass ratios, 1:5) and dialyzed against PBS solution. The dialysis of free curcumin as a control was also conducted at pH 7.4 in a PBS solution. To decide the loading concentration of curcumin into P, the quantity of curcumin in the dialysate was determined by HPLC and then deducted from the total quantity of added curcumin. The loading capacity of curcumin was 32.3% by calculating, expressed as the mass ratios of loaded curcumin to the polymeric compounds host ([Table S1](#SD4-ijn-13-1945){ref-type="supplementary-material"}).

Characterization estimation of PBLG-PEG-PBLG and curcumin/P
-----------------------------------------------------------

The P and curcumin/P were observed through TEM and particle size analyzer and the images are depicted in [Figures 2](#f2-ijn-13-1945){ref-type="fig"} and [S2B](#SD2-ijn-13-1945){ref-type="supplementary-material"}. The particle sizes of P and curcumin/P were ∼12 and ∼30 nm, respectively; the P and curcumin/P showed an orbicular structure and the diameters were ∼47 nm and ∼85 nm, respectively ([Table S1](#SD4-ijn-13-1945){ref-type="supplementary-material"}).

In vitro releases of curcumin from P
------------------------------------

The release of curcumin from P was measured via a dialysis method at 37°C, using 5 mL of curcumin-encapsulated P. The cumulative release ratio of curcumin from curcumin/P is shown in [Figure 3](#f3-ijn-13-1945){ref-type="fig"}. After 0.25 h, ∼9.9% of the curcumin was released from curcumin/P, indicative of an initial burst release of curcumin. Approximately 94.1% of the curcumin was released after 3 days.

Plasma curcumin level
---------------------

Pharmacodynamic study showed that, in rats treated with curcumin solution, initially the blood curcumin level increased rapidly, reaching the peak within 0.25 h (28,300 ng/mL), followed by a significant decline after 4 h (0 ng/mL; [Figure 4](#f4-ijn-13-1945){ref-type="fig"}). In contrast, the level of the curcumin/P complex gradually peaks within 2 h (19,860 ng/mL) and remains at a comparatively low level by 3 days (8 ng/mL on day 3; [Figure 4](#f4-ijn-13-1945){ref-type="fig"}).

Previous studies had affirmed that curcumin exhibited low water solubility, low bioavailability, and short halftime.[@b34-ijn-13-1945]--[@b36-ijn-13-1945] In this study, the blood curcumin level revealed that P could improve the pharmacological action and half-time of curcumin.

Histopathologic assessment in DM-4w/8w group
--------------------------------------------

Light microscopy image of myocardium sections are shown in [Figure 5A](#f5-ijn-13-1945){ref-type="fig"}. The disordered arrangement of myocardial cells, inflammatory reactions, T-cell and activated macrophage infiltration, edema, myofibril disarray, cell death, fibrosis, myocardial cell membrane rupture and fuzzy edges, vacuolar degeneration, and derangement were observed in histological specimen from the DM-4w group ([Figure 5A-a](#f5-ijn-13-1945){ref-type="fig"}) but were absent in the Sham group ([Figure 5A-b](#f5-ijn-13-1945){ref-type="fig"}). Histological alteration was aggravated in specimens from the DM-8w group ([Figure 5A-c](#f5-ijn-13-1945){ref-type="fig"}) compared to the DM-4w group. The quantitative analysis of histological alteration is shown in [Figure 5A-d](#f5-ijn-13-1945){ref-type="fig"}.

Based on a previous document,[@b55-ijn-13-1945] in the current study, diabetes induced the myocardial damage in DM-4W group and aggravated myocardial injury in DM-8w group compared to Sham group. The results showed that DCM model was successfully established.

Blood glucose, Chol, TG, and insulin levels in DM-4w/8w group
-------------------------------------------------------------

Blood glucose levels were observed in DM-4w and DM-8w ([Figure 5B](#f5-ijn-13-1945){ref-type="fig"}) groups and were higher in the DM-4w group (*p*\<0.01; blood glucose: Sham group 4.1±1.6 mmol/L, DM-4w group 19.8±3.3 mmol/L) and significantly higher in the DM-8w group (*p*\<0.01; blood glucose: DM-8w group 21.2±2.4 mmol/L) when compared to the Sham group.

Levels of Chol were observed in DW-4w and DW-8w ([Figure 5B](#f5-ijn-13-1945){ref-type="fig"}) groups and were significantly higher in the DM-4w group (*p*\<0.01; Chol: Sham group 1.02±0.89 mmol/L, DM-4w group 24.53±3.17 mmol/L) and DM-8w group (*p*\<0.01; Chol: DM-8w group 22.06±2.65 mmol/L) than in the Sham group.

Levels of TG were observed in DM-4w and DM-8w ([Figure 5B](#f5-ijn-13-1945){ref-type="fig"}) groups and were significantly higher in the DM-4w group (*p*\<0.01; TG: Sham group 0.41±0.11 mmol/L, DM-4w group 4.21±1.02 mmol/L) and DM-8w group (*p*\<0.01; TG: DM-8w group 3.91±0.78 mmol/L) than in the Sham group.

Levels of serum insulin were observed in DM-4w and DM-8w groups ([Figure 5C](#f5-ijn-13-1945){ref-type="fig"}) and were higher in the DM-4w group (*p*\<0.01; serum insulin: Sham group 232.38±21.38 pmol/L, DM-4w group 498.76±29.86 pmol/L) and significantly higher in DM-8w group (*p*\<0.01; serum insulin: DM-8w group 613.29±34.11 pmol/L) than in the Sham group.

Based on previous literature,[@b18-ijn-13-1945] in this study, a high-glucose and high-fat diet combined with intraperitoneal injection of small dose of STZ was used to replicate the animal model of type 2 DCM in rats. When compared to the Sham group, blood glucose, TG, and Chol levels increased significantly in model group rats. Serum insulin levels were also significantly increased in the model group rats, indicating the occurrence of insulin resistance. The results showed that this experiment successfully established a rat animal model of type 2 DCM.

CaSR and CSE expression in DM-4w/8w group
-----------------------------------------

CaSR expression in DM-4w and DM-8w ([Figure 6A](#f6-ijn-13-1945){ref-type="fig"}) groups and was lower in the DM-4w group than in the Sham group, the CaSR expression was significantly lower than in the Sham group; CSE expression in DM-4w and DM-8w ([Figure 6B](#f6-ijn-13-1945){ref-type="fig"}) groups and was lower in the DM-4w group than in the Sham group, the CSE expression was significantly lower than in the Sham group. CaSR expression in the DM-8w+CaRS group ([Figure 6C](#f6-ijn-13-1945){ref-type="fig"}) was significantly higher than in the Sham group. CSE expression in the DM-8w+CaRS ([Figure 6D](#f6-ijn-13-1945){ref-type="fig"}) group was significantly higher than in the Sham group; CSE expression in the DM-8w+CaRS+PAG group ([Figure 6E](#f6-ijn-13-1945){ref-type="fig"}) was higher than in the Sham group.

The pathogenesis of DCM was very complex. We authenticated that the expression of CaSR and CSE decreased in DM-4w and DM-8w groups, and the expression of CaSR and CSE were significantly lower in DM-8w than that in DM-4w group. The result showed that the expression of myocardial CaSR and CSE in diabetic rats decreased in a time-dependent manner and closely related to the changes of myocardial histopathological damage. Previous literature had proved that the decreased expression of CaSR and CSE in rat mesenteric arteries were one of the important causes for diabetic vascular complications.[@b50-ijn-13-1945] Other organs in diabetic or obese rats were the same as the myocardium we observed, and the expression of CaSR and CSE were also reduced. On the other hand, it also showed that CaSR modulated CSE to regulate DCM in this study.

Effect of CaRS and CaRI on histopathologic assessment, CaSR, CaM, and CSE expression, H~2~S and \[Ca2^+^\]~i~ levels
--------------------------------------------------------------------------------------------------------------------

Light microscopy images of myocardium sections in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 7A](#f7-ijn-13-1945){ref-type="fig"}. The disordered arrangement of myocardial cells, inflammatory reactions, T-cell and activated macrophage infiltration, edema, myofibril disarray, cell death, fibrosis, myocardial cell membrane rupture and fuzzy edges, vacuolar degeneration, and derangement were observed in the histological specimens from the DM-8w group ([Figure 7A-a](#f7-ijn-13-1945){ref-type="fig"}) but were absent in the Sham group ([Figure 7A-b](#f7-ijn-13-1945){ref-type="fig"}). The histopathologic damage in the Curcumin, Curcumin+CaRS, and Curcumin+CaRI groups was lower than that in the DM-8w group ([Figure 7A-c, e, g](#f7-ijn-13-1945){ref-type="fig"}); the histopathologic damage in Curcumin/P, Curcumin/P+CaRS, and Curcumin/P+CaRI groups was significantly lower than in the DM-8w group ([Figure 7A-d, f, h](#f7-ijn-13-1945){ref-type="fig"}). The quantitative analysis of histological assessment is shown in [Figure 7A-i](#f7-ijn-13-1945){ref-type="fig"}.

CaSR expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 8B](#f8-ijn-13-1945){ref-type="fig"}. The CaSR expression was significantly lower in the DM-8w group than that in the Sham group ([Figure 7B-a, b](#f7-ijn-13-1945){ref-type="fig"}); the CaSR expression was higher in the Curcumin, Curcumin+CaRS, and Curcumin+CaRI groups than that in the DM-8w group ([Figure 7B-c, e, g](#f7-ijn-13-1945){ref-type="fig"}), the CaSR expression was significantly higher in the Curcumin/P, Curcumin/P+CaRS, and Curcumin/P+CaRI groups than in the DM-8w group ([Figure 7B-d, f, h](#f7-ijn-13-1945){ref-type="fig"}). The quantitative analysis of CaSR expression is shown in [Figure 7B-i](#f7-ijn-13-1945){ref-type="fig"}.

CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 7C](#f7-ijn-13-1945){ref-type="fig"}. The CSE expression was significantly lower in DM-8w group than that in Sham group ([Figure 7C-a, b](#f7-ijn-13-1945){ref-type="fig"}). The CSE expression was higher in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group than in DM-8w group ([Figure 7C-c, e, g](#f7-ijn-13-1945){ref-type="fig"}). The CSE expression was significantly higher in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group than that in DM-8w group ([Figure 7C-d, f, h](#f7-ijn-13-1945){ref-type="fig"}). The quantitative analysis of CSE expression is shown in [Figure 7C-i](#f7-ijn-13-1945){ref-type="fig"}.

H~2~S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 7D](#f7-ijn-13-1945){ref-type="fig"}. The H~2~S level was significantly lower in DM-8w group than that in Sham group (*p*\<0.01; H~2~S level: Sham group 39.1±2.79 mol/L, DM-8w group 11.3±1.18 mol/L). The H~2~S level was higher in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group than that in DM-8w group (*p*\<0.01; H~2~S level: Curcumin group 17.9±1.94 mol/L, Curcumin+CaRS group 19.6±1.66 mol/L, Curcumin+CaRI group 15.4±1.47 mol/L). The H~2~S level was significantly higher in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group than that in DM-8w group (*p*\<0.01; H~2~S level: Curcumin/P group 24.2±2.01 mol/L, Curcumin/P+CaRS group 26.8±1.89 mol/L, Curcumin/ P+CaRI group 22.3±1.55 mol/L).

\[Ca^2+^\]~i~ level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 7E](#f7-ijn-13-1945){ref-type="fig"}. The \[Ca^2+^\]~i~ level was significantly lower in DM-8w group than that in Sham group (*p*\<0.01; \[Ca^2+^\]~i~ level: Sham group 179.3±4.8 nmol/L, DM-8w group 41.8±1.7 nmol/L). The \[Ca^2+^\]~i~ level was higher in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group than that in DM-8w group (*p*\<0.01; \[Ca^2+^\]~i~ level: Curcumin group 71.4±2.1 nmol/L, Curcumin+CaRS group 82.3±3.2 nmol/L, Curcumin+CaRI group 58.2±4.3 nmol/L). The \[Ca^2+^\]~i~ level was significantly higher in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group than that in DM-8w group (*p*\<0.01; \[Ca^2+^\]~i~ level: Curcumin/P group 118.9±1.6 nmol/L, Curcumin/P+CaRS group 131.5±2.7 nmol/L, Curcumin/ P+CaRI group 91.4±3.8 nmol/L).

CaM expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 7F](#f7-ijn-13-1945){ref-type="fig"}. The CaM expression was significantly lower in DM-8w group than that in Sham group ([Figure 7F-a, b](#f7-ijn-13-1945){ref-type="fig"}). The CaM expression was higher in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group than in DM-8w group ([Figure 7F-c, e, g](#f7-ijn-13-1945){ref-type="fig"}). The CaM expression was significantly higher in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/ P+CaRI group than that in DM-8w group ([Figure 7F-d, f, h](#f7-ijn-13-1945){ref-type="fig"}). The quantitative analysis of CaM expression is shown in [Figure 7F-i](#f7-ijn-13-1945){ref-type="fig"}.

CaSR, as a G protein-coupled receptor, could modulate intracellular \[Ca^2+^\]~i~ levels and promote \[Ca^2+^\] release from the endoplasmic/sarcoplasmic reticulum.[@b19-ijn-13-1945],[@b56-ijn-13-1945] Previous study had showed that increased \[Ca^2+^\]~i~ levels could promote CSE activity and regulate CSE/H~2~S via CaM/Ca^2+^ pathway in smooth muscle cells in DM.[@b50-ijn-13-1945] Some studies had affirmed that H~2~S production was physiologically modulated through calcium--calmodulin pathways.[@b12-ijn-13-1945] CaSR activation augmented the expression of p-CaMK II and CSE, while the CaM antagonist KN93 restrained the expression in smooth muscle cells in DM.[@b50-ijn-13-1945] The results showed that CaSR regulated the expression of CSE via calcium--calmodulin pathway of VSMCs.[@b50-ijn-13-1945] In this study, we found that CaSR activation could increase CSE expression and H~2~S level through upregulating CaM expression and Ca^2+^ level in DCM, while CaSR inhibition displayed opposite effect in DCM. In addition, curcumin as a yellow phenolic compound had a wide range of pharmacological effects, such as antioxidant, antitumor, anti-inflammatory, and hypolipidemic effects.[@b23-ijn-13-1945]--[@b26-ijn-13-1945] Previous studies had corroborated that curcumin revealed therapeutic effects on diabetes, diabetic nephropathy, diabetic eye disease, insulin resistance and metabolism-related diseases, and diabetes-induced endothelial dysfunction.[@b27-ijn-13-1945]--[@b31-ijn-13-1945] However, many studies found that curcumin alleviates DCM.[@b2-ijn-13-1945],[@b32-ijn-13-1945],[@b33-ijn-13-1945] In our study, both curcumin and curcumin/P reduced DCM through cross regulation effect of CaSR and endogenous CSE/H~2~S, while curcumin/P significantly decreased DCM.

Histopathologic assessment, H2S level, and CSE expression (effect of CaRS and PAG)
----------------------------------------------------------------------------------

Light microscopy images of myocardium sections in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups are shown in [Figure 8A](#f8-ijn-13-1945){ref-type="fig"}. The disordered arrangement of myocardial cells, inflammatory reactions, T-cell and activated macrophage infiltration, edema, myofibril disarray, cell death, fibrosis, myocardial cell membrane rupture and fuzzy edges, mitochondrial swelling, vacuolar degeneration, and derangement were observed in histological specimens from the DM-8w group ([Figure 8A-a](#f8-ijn-13-1945){ref-type="fig"}) but were absent in the Sham group ([Figure 8A-b](#f8-ijn-13-1945){ref-type="fig"}). The histopathologic damage in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group was lower than in DM-8w group ([Figure 8A-c, e, g](#f8-ijn-13-1945){ref-type="fig"}); the histopathologic damage in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group was significantly lower than in DM-8w group ([Figure 8A-d, f, h](#f8-ijn-13-1945){ref-type="fig"}). The quantitative analysis of histopathologic assessment is shown in [Figure 8A-i](#f8-ijn-13-1945){ref-type="fig"}.

H~2~S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups are shown in [Figure 8B](#f8-ijn-13-1945){ref-type="fig"}. The H~2~S level was significantly lower in DM-8w group than that in Sham group (*p*\<0.01; H~2~S level: Sham group 39.1±2.79 mol/L, DM-8w group 11.3±1.18 mol/L). The H~2~S level was higher in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group than that in DM-8w group (*p*\<0.01; H~2~S level: Curcumin group 17.9±1.94 mol/L, Curcumin+PAG group 13.1±1.78 mol/L, Curcumin+CaRS+PAG group 14.7±1.59 mol/L). The H~2~S level was significantly higher in Curcumin/P group, Curcumin/ P+PAG group, and Curcumin/P+CaRS+PAG group than that in DM-8w group (*p*\<0.01; H~2~S level: Curcumin/P group 24.2±2.01 mol/L, Curcumin/P+PAG group 19.5±2.11 mol/L, Curcumin/P+CaRS+PAG group 21.4±1.87 mol/L).

CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups are shown in [Figure 8C](#f8-ijn-13-1945){ref-type="fig"}. The CSE expression was significantly lower in DM-8w group than that in Sham group (*p*\<0.01). The CSE expression was higher in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group than that in DM-8w group (*p*\<0.01). The CSE expression was significantly higher in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group than in DM-8w group (*p*\<0.01).

Literature had showed that CaSR-mediated H~2~S production in VSMCs through Ca^2+^ signaling could modulate the proliferation of VSMCs,[@b50-ijn-13-1945] and we found that CaSR could regulate CSE/H~2~S pathway to modulate DCM in this study. Both curcumin and curcumin/P alleviated DCM through CaSR-mediated endogenous CSE/H~2~S pathway, while curcumin/P remarkably alleviated DCM.

Cell apoptosis
--------------

Cardiac cell apoptosis in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups are shown in [Figure 9A](#f9-ijn-13-1945){ref-type="fig"}. The cardiac cell apoptosis was significantly higher in DM-8w group than that in Sham group ([Figure 9A-a, b](#f9-ijn-13-1945){ref-type="fig"}). The cardiac cell apoptosis was lower in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group than that in DM-8w group ([Figure 9A-c, e, g](#f9-ijn-13-1945){ref-type="fig"}). The cardiac cell apoptosis was significantly lower in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group than that in DM-8w group ([Figure 9A-d, f, h](#f9-ijn-13-1945){ref-type="fig"}).

Cardiac cell apoptosis in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups are shown in [Figure 9B](#f9-ijn-13-1945){ref-type="fig"}. The cardiac cell apoptosis was significantly higher in DM-8w group than that in Sham group ([Figure 9B-a, b](#f9-ijn-13-1945){ref-type="fig"}). The cardiac cell apoptosis was lower in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group than in DM-8w group ([Figure 9B-c, e, g](#f9-ijn-13-1945){ref-type="fig"}). The cardiac cell apoptosis was significantly lower in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group than in DM-8w group ([Figure 9B-d, f, h](#f9-ijn-13-1945){ref-type="fig"}).

Growing evidence supported that CaSR could regulate CSE/H~2~S to modulate apoptosis via CaM/Ca^2+^ pathway in smooth muscle cells in DM.[@b50-ijn-13-1945] In our study, we found that CaSR activation promoted CSE expression and H~2~S level to inhibit apoptosis in DCM, and both CaSR and CSE inhibitors could increase apoptosis in DCM. These results showed that the cross regulation effect of CaSR and endogenous CSE/ H~2~S modulated DCM. Previous documents had proved that curcumin could inhibit apoptosis,[@b57-ijn-13-1945],[@b58-ijn-13-1945] and our research findings also found that curcumin and curcumin/P both could restrained apoptosis to alleviate DCM by the cross regulation effect of CaSR and endogenous CSE/H~2~S, while curcumin/P remarkably restrained apoptosis to alleviate DCM.

To sum up, this study showed that synthesized P could significantly improve the bioactivity, water solubility, and short half-life of curcumin. In addition, it demonstrated that curcumin and curcumin/P preconditioning were both capable of reducing DCM, and curcumin/P preconditioning significantly reduced DCM through the cross regulation effect of CaSR and endogenous CSE/H~2~S.

Conclusion
==========

The use of P as a curcumin delivery carrier not only improved half-time and bioactivity but also enhanced water solubility of curcumin. The design of P with low cytotoxicity and high efficiency was important for developing a successful curcumin delivery system. In our study, P as a curcumin nanocarrier with biodegradability and high loading capacity enhanced the pharmacological action of curcumin. Both curcumin and curcumin/P could decrease DCM through the cross regulation effect of CaSR and endogenous CSE/H~2~S.

Supplementary materials
=======================

###### 

The synthesis of PBLG-PEG-PBLG (P).

**Abbreviations:** H~2~N-PEG-NH~2~, amine poly(ethylene glycol) amine; DMF, N, N-dimethylformamide; P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate).

###### 

^1^H NMR spectra of P (**A**), diameter of P in PB (**B**-a), and diameter of curcumin/P complexes in PB (**B**-b).

**Abbreviations:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate); ^1^H NMR, ^1^H-nuclear magnetic resonance; PB, phosphate buffer.

###### 

The cellular viability of H9C2 cells cultured with different concentrations of P and curcumin/P.

**Abbreviation:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate).

###### 

Molecular weights, particle size, TEM, and curcumin-loading capacity of P

  Sample       *M*~n~ (kDa)/^1^H NMR   Particle size (nm)   TEM (nm)   Loading capacity (%)
  ------------ ----------------------- -------------------- ---------- ----------------------
  P            29.8                    12                   47         NA
  Curcumin/P   NA                      30                   85         32.3

**Abbreviations:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate); ^1^H NMR, 1H-nuclear magnetic resonance; TEM, transmission electron microscopy; *M*~n~, number-average molecular weight; NA, not applicable.
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![The structure of PBLG-PEG-PBLG (P).\
**Abbreviation:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl [l]{.smallcaps}-glutamate).](ijn-13-1945Fig1){#f1-ijn-13-1945}

![The TEM images of P and curcumin/P.\
**Notes:** (**A**) TEM of PBLG-PEG-PBLG; (**B**) TEM of curcumin/PBLG-PEG-PBLG.\
**Abbreviations:** TEM, transmission electron microscopy; P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate).](ijn-13-1945Fig2){#f2-ijn-13-1945}

![The cumulative releasing profile of free curcumin and curcumin from curcumin/P complexes and results are expressed as mean ± standard deviation.\
**Abbreviation:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl [l]{.smallcaps}-glutamate).](ijn-13-1945Fig3){#f3-ijn-13-1945}

![Blood curcumin concentrations of curcumin and curcumin from curcumin/P complexes in rats and results are expressed as mean ± standard deviation.\
**Abbreviation:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly (gamma-benzyl [l]{.smallcaps}-glutamate).](ijn-13-1945Fig4){#f4-ijn-13-1945}

![(**A**) Histopathologic assessment of myocardial damage; (**B**) blood glucose, Chol, and TG levels; (**C**) serum insulin level.\
**Notes:** (**A**) Light microscope images (×100) in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of histopathologic assessment is shown in "d". Results are expressed as mean ± SD. A significant increase from Sham group is denoted by \**p*\<0.01, and a significant increase from DW-4w group is denoted by \*\**p*\<0.01. (**B**) The blood of Sham, DM-4w, and DM-8w groups were collected, and the levels of blood glucose, Chol, and TG were measured. Results are expressed as mean ± SD. A significant increase from Sham group is denoted by \**p*\<0.01, and a significant increase from DW-4w group is denoted by \*\**p*\<0.01. (**C**) The blood of Sham, DM-4w, and DM-8w groups were collected and the levels of serum insulin were measured. Results are expressed as mean ± SD. A significant increase from Sham group is denoted by \**p*\<0.01, and a significant increase from DW-4w groups is denoted by \*\**p*\<0.01.\
**Abbreviations:** DM, diabetes mellitus; Chol, cholesterol; TG, triglyceride; SD, standard deviation.](ijn-13-1945Fig5){#f5-ijn-13-1945}

![(**A**) CaSR expression in Sham, DM-4w, and DM-8w groups; (**B**) CSE expression in Sham, DM-4w, and DM-8w groups; (**C**) CaSR expression in Sham and DM-8w+CaRS groups; (**D**) CSE expression in Sham and DM-8w+CaRS groups; (**E**) CSE expression in Sham and DM-8w+CaRS+PAG groups.\
**Notes:** (**A**) CaSR expression in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of CaSR expression is shown in "d". Results are expressed as mean ± SD. (**B**) CSE expression in Sham group (a), DM-4w group (b), and DM-8w group (c). The quantitative analysis of CSE expression is shown in "d". Results are expressed as mean ± SD. (**C**) CaSR expression in Sham group (a), DM-8w+CaRS group (b). The quantitative analysis of CaSR expression is shown in "c". Results are expressed as mean ± SD. (**D**) CSE expression in Sham group (a) and DM-8w+CaRS group (b). The quantitative analysis of CSE expression is shown in "c". Results are expressed as mean ± SD. (**E**) CSE expression in Sham group (a) and DM-8w+CaRS+PAG group (b). The quantitative analysis of CSE expression is shown in "c". Results are expressed as mean ± SD. Magnification is ×100. A significant decrease from Sham group is denoted by \**p*\<0.01, and a significant decrease from DW-4w group is denoted by \*\**p*\<0.01.\
**Abbreviations:** CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; PAG, DL-propargylglycine.](ijn-13-1945Fig6){#f6-ijn-13-1945}

###### 

(**A**) Histopathologic assessment of myocardial damage; (**B**) CaSR expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (**C**) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (**D**) H~2~S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (**E**) \[Ca^2+^\]~i~ level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups; (**F**) CaM expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups.

**Notes:** (**A**) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of histopathological assessment is shown in "i". The histopathologic damage in DM-8w group is higher than that in Sham group (*p*\<0.01), and the histopathologic damage in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group (*p*\<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group (*p*\<0.01). (**B**) CaSR expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/ P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaSR expression is shown in "B-i". The CaSR expression in DM-8w group is lower than that in Sham group (*p*\<0.01), and the CaSR expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (*p*\<0.01); the CaSR expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (*p*\<0.01). (**C**) CSE expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CSE expression is shown in "C-i". The CSE expression in DM-8w group is lower than that in Sham group (*p*\<0.01), and the CSE expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (*p*\<0.01); the CSE expression in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (*p*\<0.01). (**D**) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of H~2~S were measured. Results are expressed as mean ± SD. (**E**) The cardiac cells of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups were collected and the levels of \[Ca^2+^\]~i~ were measured. Results are expressed as mean ± SD. (**F**) CaM expression in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The quantitative analysis of CaM expression is shown in "i". The CaM expression in DM-8w group is lower than that in Sham group (*p*\<0.01), and the CaM expression in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is higher than that in DM-8w group (*p*\<0.01); the CaM expression in Curcumin/P group, Curcumin/ P+CaRS group, and Curcumin/P+CaRI group is significantly higher than that in DM-8w group (*p*\<0.01). A significant decrease from Sham group is denoted by \**p*\<0.01, a significant increase from DM-8w group is denoted by \*\**p*\<0.01, and a significant increase from DM-8w group is denoted by \*\*\**p*\<0.01.

**Abbreviations:** CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; CaM, calmodulin; P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate); SD, standard deviation.
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![(**A**) Histopathologic assessment of myocardial damage; (**B**) H~2~S level in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+ CaRS+PAG, and Curcumin/P+CaRS+PAG groups; (**C**) CSE expression in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups.\
**Notes:** (**A**) Light microscope images (×100) in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+PAG group (e), Curcumin/P+PAG group (f), Curcumin+CaRS+PAG group (g), and Curcumin/P+CaRS+PAG group (h). The quantitative analysis of histopathologic assessment is showed in "i". The histopathologic damage in DM-8w group is higher than that in Sham group (*p*\<0.01), and the histopathologic damage in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group is lower than that in Sham group (*p*\<0.01); the histopathologic damage in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group is significantly lower than that in Sham group (*p*\<0.01). (**B**) The blood of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups were collected and the levels of H~2~S were measured. Results are expressed as mean ± SD. (**C**) The cardiac tissues of Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/P+CaRS+PAG groups and the expression of CSE were measured. Results are expressed as mean ± SD. A significant decrease from Sham group is denoted by \**p*\<0.01, a significant increase from DM-8w group is denoted by \*\**p*\<0.01, and a significant increase from DM-8w group is denoted by \*\*\**p*\<0.01.\
**Abbreviations:** CaSR, calcium-sensing receptor; DM, diabetes mellitus; CSE, cystathionine-γ-lyase; CaRS, calcium-sensing receptor stimulator; PAG, DL-propargylglycine; CaM, calmodulin; P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate); SD, standard deviation.](ijn-13-1945Fig8){#f8-ijn-13-1945}

![(**A**) Apoptosis assessment of cardiac cells in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+CaRS, Curcumin/P+CaRS, Curcumin+CaRI, and Curcumin/P+CaRI groups. (**B**) Apoptosis assessment of cardiac cell in Sham, DM-8w, Curcumin, Curcumin/P, Curcumin+PAG, Curcumin/P+PAG, Curcumin+CaRS+PAG, and Curcumin/ P+CaRS+PAG groups.\
**Notes:** (**A**) Apoptosis in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+CaRS group (e), Curcumin/P+CaRS group (f), Curcumin+CaRI group (g), and Curcumin/P+CaRI group (h). The apoptosis in DM-8w group is higher than that in Sham group, and the apoptosis in Curcumin group, Curcumin+CaRS group, and Curcumin+CaRI group is lower than that in DM-8w group; the apoptosis in Curcumin/P group, Curcumin/P+CaRS group, and Curcumin/P+CaRI group is significantly lower than that in DM-8w group. (**B**) Apoptosis in Sham group (a), DM-8w group (b), Curcumin group (c), Curcumin/P group (d), Curcumin+PAG group (e), Curcumin/P+PAG group (f), Curcumin+CaRS+PAG group (g), and Curcumin/P+CaRS+PAG group (h). The apoptosis in DM-8w group is higher than that in Sham group, and the apoptosis in Curcumin group, Curcumin+PAG group, and Curcumin+CaRS+PAG group is lower than that in DM-8w group; the apoptosis in Curcumin/P group, Curcumin/P+PAG group, and Curcumin/P+CaRS+PAG group is significantly lower than that in DM-8w group. Magnification is ×100.\
**Abbreviations:** CaSR, calcium sensing receptor; DM, diabetes mellitus; CaRS, calcium-sensing receptor stimulator; CaRI, calcium-sensing receptor inhibitor; P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate); PAG, DL-propargylglycine.](ijn-13-1945Fig9){#f9-ijn-13-1945}

![Encapsulation of curcumin by PBLG-PEG-PBLG (P).\
**Abbreviation:** P, poly(gamma-benzyl [l]{.smallcaps}-glutamate)-poly(ethylene glycol)-poly(gamma-benzyl [l]{.smallcaps}-glutamate).](ijn-13-1945Fig10){#f10-ijn-13-1945}
